{"schema_version":"secwatch.filing_event.v1","accession":"0001626199-24-000063","form_type":"8-K","ticker":null,"cik":"0001626199","company_name":"ALPINE IMMUNE SCIENCES, INC.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.307849+00:00","generated_at":"2026-06-02T06:05:55.524232+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Vertex to acquire Alpine Immune for $65/share; Q1 net loss $17.9M","bullets":["Vertex acquires Alpine for $65 per share in cash; transaction unanimously approved, expected to close in Q2 2024.","Q1 net loss $17.9M ($0.28 per share) vs $13.3M loss in Q1 2023.","Cash and investments $362.4M as of March 31, 2024; sufficient to fund operations into 2026.","Collaboration revenue $7.0M, down from $9.4M; R&D expense up to $22.5M from $19.6M."],"urls":{"canonical":"https://secwatch.observer/filing/0001626199-24-000063","json":"https://secwatch.observer/filing/0001626199-24-000063.json","markdown":"https://secwatch.observer/filing/0001626199-24-000063.md","text":"https://secwatch.observer/filing/0001626199-24-000063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626199/000162619924000063/0001626199-24-000063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626199/000162619924000063/alpn-20240509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T06:05:55.524232+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b6f36fd3c46256d7027829977540396d65546086","claim":"ALPINE IMMUNE SCIENCES, INC. reported financial results for first quarter ended March 31, 2024.","evidence_excerpt":"On May 9, 2024, Alpine Immune Sciences, Inc. issued a press release reporting its financial results for the three months ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626199/000162619924000063/0001626199-24-000063-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}